Real-time enrollment status for this solid tumors clinical trial
Current Status
Recruiting
Checked: July 22, 2026 at 2:18 PM UTC
| NCT Number | NCT06244992 |
| Recruiting Status | Recruiting |
| Condition | Solid Tumors |
| Phase | PHASE1 |
| Target Enrollment | 68 participants |
| Active Locations | 3 sites in the US |
| Sponsor | Pyrotech Therapeutics, Inc. |
| Last Updated on CT.gov | March 12, 2025 (Mar 12, 2025) |
As of July 22, 2026: Clinical trial NCT06244992 is currently recruiting participants. This phase1 study for solid tumors is actively seeking new participants at 3 locations across the United States. The study is sponsored by Pyrotech Therapeutics, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06244992 is actively recruiting participants as of July 22, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 3 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06244992 was last updated Mar 12, 2025 (March 12, 2025). HelloStudys verifies this status automatically.